Evaluation of direct from sample metabolomics of human feces using rapid evaporative ionization mass spectrometry
File(s)stool_analchem_revision_esi_vf.pdf (1.93 MB) stool_analchem_revision_vf.pdf (1.5 MB)
Supplementary information
Accepted version
Author(s)
Type
Journal Article
Abstract
Mass spectrometry is a powerful tool in the investigation of the human fecal metabolome. However, current approaches require time-consuming sample preparation, chromatographic separations, and consequently long analytical run times. Rapid evaporative ionization mass spectrometry (REIMS) is a method of ambient ionization mass spectrometry and has been utilized in the metabolic profiling of a diverse range of biological materials, including human tissue, cell culture lines, and microorganisms. Here, we describe the use of an automated, high-throughput REIMS robotic platform for direct analysis of human feces. Through the analysis of fecal samples from five healthy male participants, REIMS analytical parameters were optimized and used to assess the chemical information obtainable using REIMS. Within the fecal samples analyzed, bile acids, including primary, secondary, and conjugate species, were identified, and phospholipids of possible bacterial origin were detected. In addition, the effect of storage conditions and consecutive freeze/thaw cycles was determined. Within the REIMS mass spectra, the lower molecular weight metabolites, such as fatty acids, were shown to be significantly affected by storage conditions for prolonged periods at temperatures above −80 °C and consecutive freeze/thaw cycles. However, the complex lipid region was shown to be unaffected by these conditions. A further cohort of 50 fecal samples, collected from patients undergoing bariatric surgery, were analyzed using the optimized REIMS parameters and the complex lipid region mass spectra used for multivariate modeling. This analysis showed a predicted separation between pre- and post-surgery specimens, suggesting that REIMS analysis can detect biological differences, such as microbiome-level differences, which have traditionally been reliant upon methods utilizing extensive sample preparations and chromatographic separations and/or DNA sequencing.
Date Issued
2019-11-05
Date Acceptance
2019-10-04
Citation
Analytical Chemistry, 2019, 91 (21), pp.13448-13457
ISSN
0003-2700
Publisher
American Chemical Society
Start Page
13448
End Page
13457
Journal / Book Title
Analytical Chemistry
Volume
91
Issue
21
Copyright Statement
© 2019 American Chemical Society
Sponsor
Imperial College Healthcare NHS Trust- BRC Funding
Biotechnology and Biological Sciences Research Council (BBSRC)
Medical Research Council (MRC)
Commission of the European Communities
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000495469100020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
RDB04
BB/L020858/1
MR/P002536/1
715662
Subjects
Science & Technology
Physical Sciences
Chemistry, Analytical
Chemistry
BARIATRIC SURGERY
GUT MICROBIOTA
HEALTH
PROFILE
IDENTIFICATION
INFLAMMATION
BIOMARKER
BACTERIA
OBESE
Publication Status
Published
Date Publish Online
2019-10-04